Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: Central and peripheral influences

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF01252030PMID 4067598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depressionsyndrom

  2005cited by this paper
• Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: Peripheral origin of glucuronide

  2004cited by this paper
• Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites.

  1984cited by this paper
• Genetic studies of CSF monoamine metabolites.

  1984cited by this paper
• Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites.

  1984cited by this paper
• Studies on the central or peripheral origin of free and sulfated 3,4-dihydroxyphenylacetic acid in rat plasma.

  1984cited by this paper
• Frontiers in Biochemical and Pharmacological Research in Depression

  1984cited by this paper
• Disposition and Metabolism of MHPG in Humans: Application to Studies in Depression

  1984cited by this paper
• Current theories on the mode of action of antidepressant drugs.

  1984cited by this paper
• Covariance of plasma free 3-methoxy-4-hydroxyphenethyleneglycol and diastolic blood pressure.

  1981cited by this paper
• Urinary MHPG, stress response, personality factors and somatosensory evoked potentials in normal subjects and patients with major affective disorders.

  1981cited by this paper
• Toward a biochemical classification of depressive disorders

  1981cited by this paper
• 4‐HYDROXY‐3‐METHOXYPHENYLGLYCOL AS AN INDEX OF BRAIN NORADRENALINE TURNOVER IN ENDOGENOUS DEPRESSION

  1980cited by this paper
• MHPG excretion and EEG sleep in primary depression.

  1980cited by this paper
• 4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depression.

  1980cited by this paper
• Urinary MHPG in subgroups of depressed patients and normal controls.

  1980cited by this paper
• Reduction in human urinary MHPG excretion by guanethidine: urinary MHPG as index of sympathetic nervous activity.

  1979cited by this paper
• 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.

  1979cited by this paper
• Response to amitriptyline and urinary MHPG in bipolar depressive patients.

  1979cited by this paper
• Biogenic amine hypotheses of affective disorders.

  1979cited by this paper
• NOREPINEPHRINE METABOLITE STUDIES IN AFFECTIVE ILLNESS

  1979cited by this paper
• ROLE OF THE NUCLEUS LOCUS COERULEUS IN SYMPATHETHIC AND CENTRAL NORADRENERGIC ACTIVATION AS REFLECTED BY CHANGES IN THE NOREPINEPHRINE METABOLITE 3-METHOXY-4-HYDROXYPHENETHYLENEGLYCOL (MHPG) IN RATS

  1979cited by this paper
• Biogenic amine hypothesis of affective disorders

  1979cited by this paper
• 3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo.

  1979cited by this paper
• Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.

  1978cited by this paper
• The switch process in manic‐depressive illness

  1978cited by this paper
• Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.

  1978cited by this paper
• Excretion of MHPG in normal subjects: implications for biological classification of affective disorders.

  1978cited by this paper
• Primary affective disorder, clinical state change, and MHPG excretion: a longitudinal study.

  1978cited by this paper
• State anxiety, physical activity, and urinary 3-methoxy-4-hydroxyphenethylene glycol excretion.

  1978cited by this paper
• Psychopharmacology: A generation of progress

  1978cited by this paper
• Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma.

  1977cited by this paper
• Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients

  1976cited by this paper
• Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities.

  1975cited by this paper
• Urinary excretion of the sulphate and glucuronide of 3-methoxy-4-hydroxyphenylethyleneglycol in a manic-depressive patient

  1975cited by this paper
• Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline.

  1975cited by this paper
• MHPG excretion by patients with affective disorders.

  1974cited by this paper
• Biochemical Criteria for Classifying Depressive Disorders and Predicting Responses to Pharmacotherapy: Preliminary Findings from Studies of Norepinephrine Metabolism

  1974cited by this paper
• Measurement of the two conjugates of 3-methoxy-4-hydroxyphenyglycol in urine.

  1974cited by this paper
• SULFATE CONJUGATES IN THE BRAIN

  1973cited by this paper
• Relation of exercise to MHPG excretion in normal subjects.

  1973cited by this paper
• Desynchronized sleep and MHPG excretion: an inverse correlation.

  1973cited by this paper
• THE IDENTIFICATION OF DEPRESSED PATIENTS WHO HAVE A DISORDER OF NE METABOLISM AND/OR DISPOSITION

  1973cited by this paper
• The "switch process" in manic-depressive illness. 3. Theoretical implications.

  1972cited by this paper
• Effect of physical activity on urinary M.H.P.G. excretion in depressed patients.

  1972cited by this paper
• Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients

  1972cited by this paper
• Diagnostic criteria for use in psychiatric research.

  1972cited by this paper
• Resting plasma catecholamine concentrations in patients with depression and anxiety.

  1971cited by this paper
• Catecholamine Metabolism, Depression and Stress

  1971cited by this paper
• The Stress of Aircraft Carrier Landings: II. 3‐Methoxy‐4‐Hydroxyphenylglycol Excretion in Naval Aviators

  1970cited by this paper
• Metabolism of catecholamines--identification and quantification of 3-methoxy-4-hydroxyphenylglycol glucuronide in human urine.

  1969cited by this paper
• 3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid.

  1968cited by this paper
• 3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study.

  1968cited by this paper
• Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

  1968cited by this paper
• 3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid.

  1968cited by this paper
• In vivo studies of the metabolism of norepinephrine in the central nervous system.

  1968cited by this paper
• [Determination of urinary creatinine].

  1955cited by this paper
• Recherches sur le dosage de la créatinine urinaire.

  1955cited by this paper

• A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites.

  2018cites this paper
• An Ultrahigh-Performance Liquid Chromatography-Time-of-Flight Mass Spectrometry Metabolomic Approach to Studying the Impact of Moderate Red-Wine Consumption on Urinary Metabolome.

  2018cites this paper
• The urinary metabolomic profile following the intake of meals supplemented with a cocoa extract in middle-aged obese subjects.

  2016cites this paper
• Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary

  2005cites this paper
• Effect of cytidine(5′)diphosphocholine (CDP-Choline) on the total urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) by rats and humans

  2005cites this paper
• Comparison of a 4-day confinement and head-down tilt on endocrine response and cardiovascular variability in humans

  2004cites this paper
• Relationships between catecholamine or 3-methoxy 4-hydroxy phenylglycol changes and the mental performance under submaximal exercise in man

  2004cites this paper
• Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis

  1998cites this paper
• Hormonal response to restraint in rhesus monkeys

  1996cites this paper
• Assay of urinary free and conjugated 3-methoxy-4-hydroxyphenylethyleneglycol by high-performance liquid chromatography with amperometric detection.

  1995cites this paper
• Disruption of circadian MHPG rhythmicity in major depression.

  1994cites this paper
• The influence of total sleep deprivation on urinary excretion of catecholamine metabolites in major depression

  1993cites this paper
• Rapid non-enzymatic HPLC determination of total MHPG in human plasma.

  1990cites this paper
• Determination of urinary 3-methoxy-4-hydroxyphenylethylene glycol and its conjugates by high-performance liquid chromatography with electrochemical and ultraviolet absorbance detection.

  1989cites this paper
• Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

  1989cites this paper
• Gas-liquid chromatographic method for routine detection of plasma sulfo-, gluco-, and free 3-methoxy-4-hydroxyphenylglycol.

  1989cites this paper
• The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients.

  1988cites this paper
• Situational panic attacks. Behavioral, physiologic, and biochemical characterization.

  1987cites this paper